INS and polycystic ovary syndrome: Both the miRNAs were predicted to target the insulin receptor substrate proteins 2 (IRS-2), which is crucial in the insulin signaling pathway and is congruent with the relative hyperinsulinemia of the analyzed PCOS patients [50].